Use of Parties’ Names. In connection with this Agreement, each party agrees not to use the other party’s name in any form of publicity, or to release to the public any information relating to the Services to be performed hereunder, or to otherwise disclose or advertise that the other party has entered into this Agreement, except with the specific prior approval in writing of the other party.
Use of Parties’ Names a. Without Schwxx'x xxxor written consent, Fund Company will not cause or permit the use, description, or reference to Schwab, or to the relationship contemplated by this Agreement in any advertisement or promotional materials or activities.
b. Fund Company authorizes Schwab to use the names or other identifying marks of Fund Company and Fund in connection with the operation of the MFMP. Fund Company may withdraw this authorization as to any particular use of any such name or identifying marks at any time (i) upon Fund Company's reasonable determination that such use would have a material adverse effect on the reputation or marketing efforts of Fund Company or such Fund, or (ii) if any of the Funds cease to be available through the MFMP; provided, however, that Schwab may, in its discretion, continue to use materials prepared or printed prior to the withdrawal of such authorization or in the process of being prepared or printed at the time of such withdrawal.
Use of Parties’ Names. Each Party agrees that it shall not use in any ---------------------- way the name or logo of the other Party without the prior consent of the Party whose name is to be used.
Use of Parties’ Names. Nothing herein shall be construed as granting either party the right to use the other party's name in publicizing anything used under this Agreement.
Use of Parties’ Names a. Without Service Provider's prior written consent, which shall not be unreasonably withheld, Fund Affiliate will not cause or permit the use, description, or reference to Service Provider, or to the relationship contemplated by this Agreement, in any advertisement, sales literature, or other promotional materials or activities, including, without limitation, any advertisement or promotional materials published, distributed, or made available, or any activity conducted through, the Internet or any other electronic medium.
b. Service Provider shall not make any representations regarding Fund Company or Fund Affiliate without the prior written consent of Fund Affiliate, which shall not be unreasonably withheld, except as follows:
(i) Service Provider may refer to any Fund as part of a list of mutual funds available through any Program; and
(ii) Service Provider may disclose any fact or make any reference to any information concerning any Fund that is contained in and accurately derived from the Fund's current prospectus or statement of additional information, or advertising, sales literature, or other promotional materials generated or approved by Fund Affiliate. Fund Affiliate may, in its reasonable discretion, request that Service Provider modify any reference to any Fund in subsequent advertisements or sales literature.
Use of Parties’ Names. Licensee may use the following language, “Editas has licensed IP from the following institutions” and then include DUKE in the list that follows. It is understood by the Parties that general groups of companies who may see this in print would be pharmaceutical companies (and disease foundations) with whom Licensee is discussing potential partnerships and/or collaborations and potential investors. Before Licensee uses the language above in any presentation materials, Licensee will first submit an example slide to DUKE for approval before use the first time.
Use of Parties’ Names. Neither Party shall make (or have made on its behalf) any oral or written release of any statement, information, advertisement or publicity in connection with this Agreement which uses the other party’s name, symbols, or trademarks without the other Party’s prior written approval.
Use of Parties’ Names. Zomedica and Celsee will obtain prior written permission from each other before using the name, symbols, and/or marks or logotypes of the other in any form of publicity in connection with the Research Study. This shall not include legally required disclosure by the Zomedica or Celsee that identifies the existence of the Agreement. Notwithstanding the forgoing, either party may disclose the title of the Research Study and the identity of the other party in order to complete federal grant applications or to fulfill internal reporting requirements. In addition, any publication shall note the role of the other party in the Research Study. This provision shall survive termination of this Agreement.
Use of Parties’ Names. Neither Party shall advertise any connection with the other Party nor make use of the other Party’s name or other identifying marks or property, nor make representations, either express or implied, without the other Party’s prior written approval. The prior sentence shall not, however, be construed so as to prevent mention of the contribution of either Party in any scientific publication.
Use of Parties’ Names a. Without USC's prior written consent, Program Fund and Program Fund Affiliate will not cause or permit the use, description, or reference to USC, or to the relationship contemplated by this Agreement in any advertisement or promotional materials or activities.
b. Program Fund and Program Fund Affiliate authorize USC to use the names or other identifying marks of Program Fund and Program Fund Affiliate in connection with the operation of the USC NTF. Program Fund or Program Fund Affiliate may withdraw this authorization as to any particular use of any such name or identifying marks at any time (i) upon their reasonable determination that such use would have a material adverse effect on the reputation or marketing efforts of Program Fund or Program Fund Affiliate, or (ii) if any of the Program Funds cease to be available through the USC NTF; PROVIDED, HOWEVER, that USC may, in its discretion, continue to use materials prepared or printed prior to the withdrawal of such authorization or in the process of being prepared or printed at the time of such withdrawal.
